We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Methods Evaluated for Autoimmune Hemolytic Anemia Diagnosis

By LabMedica International staff writers
Posted on 21 Jun 2012
The use of both the gel test (GT) and flow cytometry (FC) techniques in the detection of red blood cell-bound immunoglobulin G (IgG) has been assessed. More...


The two tests are important in the diagnosis of autoimmune hemolytic anemia (AIHA) in cases that were negative by the conventional tube technique (CTT) or direct antiglobulin test (DAT).

Hematologists at Ain Shams University (Cairo, Egypt) conducted a case-control study between August 2008 and October 2010. The study included 50 patients, who were clinically diagnosed to have Warm Antibody AIHA with negative CTT-DAT. Fifty-five healthy volunteers with negative polyspecific CTT-DAT were also enrolled as control subjects.

Blood samples were tested by the Direct Antiglobulin Test by CTT and GT and by FC technique. In the FC assay, the results were expressed as percent fluorescence, which is the percentage of erythrocytes expressing the anti-human IgG at levels above those of the isotype control, and mean fluorescence intensity (MFI). For the GT assay, a positive test is where agglutinated cells formed a red line on gel surface or dispersed agglutinates in the gel and were graded from G1-G4. For the CTT, agglutination was detected macroscopically and confirmed by microscopic examination.

The results of the study showed that 46 of 50 (92%) patients were positive by GT. The Receiver Operating Characteristic curve for FC assay determined that a cut-off of 17.5% fluorescence was the best value for interpreting FC-DAT positively in the group of patients with hemolytic anemia, with 100% sensitivity and specificity. The best cut-off for MFI was 1.74, with 76% specificity and 96% sensitivity. Both mean percent fluorescence and MFI were significantly higher among patients when compared to controls. The FC assay was performed using the Coulter Epics XL 3-colour flow cytometer (Beckman Coulter Inc., Brea, CA, USA).

The authors concluded that GT and FC are sensitive tools for assessing CTT-DAT-negative AIHA. However, FC is more precise and so should be utilized when a strong clinical suspicion of AIHA is associated with dissonant CTT and GT results. They propose that FC percent fluorescence cut-off values should be employed to determine the Coombs’ negative AIHA cases. However, they do imply that larger studies are needed to define the best cut-off value for FC IgG DAT positivity in such cases. The study was published in the June 2012 issue of the International Journal of Laboratory Hematology.

Related Links:

Ain Shams University
Beckman Coulter Inc.



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
All-in-One Molecular System
AIO M160
New
Neurofilament Light Chain Assay
Lumipulse G NfL Blood
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Lead author Professor Chamindie Punyadeera. (Image Credit: Griffith University)

Breath Analysis Shows Promise for Distinguishing Cancerous from Benign Lung Nodules

Lung nodules are frequently detected during imaging, but distinguishing malignant from benign findings can require invasive procedures. Some patients undergo biopsies, bronchoscopy, or surgery before learning... Read more

Molecular Diagnostics

view channel
Image: Skin samples from people with a suspected genetic myopathy were examined for confirmation of disease. Brown spots show abnormal protein buildup inside the nuclei of cells (purple), typical of a type of myopathy called oculopharyngodistal myopathy. (Image Credit: Garvan Institute)

Long-Read Sequencing Test Identifies Genetic Causes in Inherited Muscle Disease

Inherited muscle diseases are highly heterogeneous and often progressive, leaving many patients without a molecular diagnosis despite extensive testing. Conventional assays typically target individual... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Each PhAST instrument supports random-access processing of up to four samples simultaneously, delivering a throughput of up to 12 samples per eight-hour shift. (Photo courtesy of PhAST)

FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures

Bloodstream infections require prompt treatment, but antimicrobial susceptibility results often lag behind a positive blood culture. Conventional testing can take another 24 to 48 hours after a culture... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.